0
Deep & Emerging Tech·October 19, 2026·1 min read

The Story of Billy Evans and ‘Theranos 2.0’

Share

The prospect of a “Theranos 2.0” — even as a narrative device — shows how fragile trust remains in consumer-facing diagnostics. Healthtech founders should over-index on transparent validation and regulatory engagement, because the market will benchmark you against these cautionary stories whether you like it or not.

Deep & Emerging Tech

A profile of Alona Katz, chief of Brooklyn DA's Virtual Currency Unit, who recently led an operation that seized and disrupted over 240 crypto fraud websites

Regulators are shifting from chasing individual scammers to disrupting the infrastructure of fraud at scale—240+ sites taken down is an infrastructure play, not a one-off bust. If you touch consumer crypto flows, assume coordinated, cross-border enforcement against the rails you use, not just the bad actors you avoid.